Investing.com -- NovaBay Pharmaceuticals (NYSE:NBY) stock tumbled 30% on Tuesday after the company announced it had entered into an at-the-market (ATM) equity offering agreement potentially worth up ...

NovaBay Pharmaceuticals Inc (NYSE:NBY) shares are lower by 66% to $0.67 over the trailing five sessions after announcing the pricing of its public offering of 3.2 million shares (or pre-funded ...

NovaBay (NBY) stock plunges as the company reaches a deal with Virtu Americas, a brokerage firm, to sell up to $100M worth of its common stock. Read more here.

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks ...

POINT CAPITAL PARTNERS LP POPLAR, a 10% owner of $NBY, bought 31,703 shares of the company on 01-27-2025 for an estimated $21,875. This trade was reported by Quiver ...

In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. NovaBay Pharmaceuticals, Inc. is one of them. NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a ...

Detailed price information for Novabay Pharmaceuticals (NBY-A) from The Globe and Mail including charting and trades.

NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering. Want to trade this news? Get access to the 34-0 income ...